TAM-NHI NGUYEN: Open Payments
NPI 1023121324 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$286 in 6 payments from 4 companies in 2025. Trend: 2023 $122 · 2024 $0 · 2025 $286
Food & beverage: $286
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC | 1 | $104 |
| Lilly USA, LLC | 1 | $95 |
| Dexcom, Inc. | 3 | $62 |
| Bard Peripheral Vascular, Inc. | 1 | $25 |
Products named: ZERBAXA, ZEPBOUND, Dexcom G6 Transmitter, BardPort M.R.I..
Industry payments across TX — which companies pay providers there.
